Mojtaba Habibagahi
Overview
Explore the profile of Mojtaba Habibagahi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farshchi M, Abdollahi E, Saghafi N, Hosseini A, Fallahi S, Rostami S, et al.
J Clin Transl Res
. 2022 Jul;
8(3):256-265.
PMID: 35813894
Background And Aim: The Th17/Treg balance in peripheral blood and reproductive tissues may have a role in the etiology of unexplained recurrent pregnancy loss (URPL). In this study, we evaluated...
2.
Zahiri L, Malekmakan L, Masjedi F, Habibagahi Z, Habibagahi M
Iran J Kidney Dis
. 2022 Mar;
1(1):13-23.
PMID: 35271496
Introduction: Elevated levels of interleukin 17A (IL-17A) have been found in systemic lupus erythematosus (SLE). Forkhead box protein P3 (FOXP3) activates T-regulation lymphocytes and is a master regulator cell function....
3.
Ariafar A, Habibagahi M, Jaberipour M, Khezri A, Hadi Khezri M, Bozorgi H, et al.
Iran J Med Sci
. 2021 Sep;
46(5):339-346.
PMID: 34539008
Background: Regulatory T cells (Tregs) play a key role in the progression of tumors. These cells express forkhead box P3 (FOXP3) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4), which are the...
4.
Attar A, Khosravi Maharlooei M, Nazarinia M, Hosseini A, Bajalli Z, Moeini Y, et al.
Iran J Pathol
. 2020 Aug;
15(3):225-231.
PMID: 32754218
Background & Objective: It is not clear whether activated lymphocytes of patients with systemic lupus erythematosus (SLE) are more proliferative or less apoptotic. We aimed to delineate potential differences between...
5.
Fakhimi M, Talei A, Ghaderi A, Habibagahi M, Razmkhah M
Cell J
. 2019 Nov;
22(2):236-244.
PMID: 31721539
Objective: Mesenchymal stem cells (MSCs) have prominent immunomodulatory roles in the tumor microenvironment. The current study intended to elucidate Treg subsets and their cytokines after exposing naïve T lymphocytes to...
6.
Vojdani Z, Babaei A, Vasaghi A, Habibagahi M, Talaei-Khozani T
Iran J Basic Med Sci
. 2016 Apr;
19(1):89-96.
PMID: 27096069
Objectives: Umbilical cord blood is a good source of the mesenchymal stem cells that can be banked, expanded and used in regenerative medicine. The objective of this study was to...
7.
Tashnizi A, Jaberipour M, Razmkhah M, Rahnama S, Habibagahi M
J Cancer Res Ther
. 2016 Apr;
12(1):221-7.
PMID: 27072241
Aim Of Study: WEE1, a member of serine/threonine protein kinase family is the master inhibitor of cyclin-dependent kinase 1 in cell cycle. Over-expression of WEE1 in glioblastomas (GBMs) and some...
8.
Ghiasi N, Habibagahi M, Rosli R, Ghaderi A, Yusoff K, Hosseini A, et al.
J Cancer Res Ther
. 2016 Feb;
11(4):708-16.
PMID: 26881506
Background: Activation of T cells against tumors by recruiting co-stimulatory molecules has been an attractive approach for cancer immunotherapy. Reports suggested that targeting different genes in tumors might also boost...
9.
Zare H, Habibagahi M, Vahdati A, Habibagahi Z
Iran J Immunol
. 2015 Sep;
12(3):166-75.
PMID: 26412635
Background: Patients with rheumatoid arthritis (RA) suffer from wide ranges of autoimmune reactions in joints. The mechanism of which is generally unknown and maybe associated with Treg deregulation. Objective: To...
10.
Khosravi-Maharlooei M, Jaberipour M, Tashnizi A, Attar A, Amirmoezi F, Habibagahi M
Int J Mol Cell Med
. 2015 Aug;
4(2):109-19.
PMID: 26261800
Telomerase and systems controlling their activity have been of great attention. There are controversies regarding the role of the alternative splicing forms of the human telomerase reverse transcriptase (hTERT), the...